-The Hindu The expenditure on providing food security will add minimally to India's public spending which is less than what even lower middle income Asian countries spend on social protection In recent media coverage, critics often argue that the cost of the National Food Security Bill (NFSB) is excessive. The Economic Times referred to the NFSB as a "money guzzling measure" and according to CNBC-TV18, Rahul Bajaj, chair of Bajaj Auto, said...

-IANS Bangalore: A leading journal of medical ethics has charged the World Health Organization (WHO) with promoting the Pentavalent vaccine in countries, including India, though it is known to have caused adverse reactions and deaths in children. In a hard-hitting editorial, the latest issue of the Indian Journal of Medical Ethics (IJME), has accused the WHO of promoting the vaccine "by stating falsely that no adverse event following immunisation (AEFI) has ever...

-The Times of India NEW DELHI: The preliminary data from the second State of Democracy in South Asia (SDSA) report shows democracy in India is thriving though the level of belief in it has dipped sharply since 2005. Findings of the three-nation survey - conducted in Sri Lanka, Nepal and India - was unveiled here on Friday. The survey in Pakistan would take place over next few months. Indian survey, conducted by...

-The Guardian Half of Indians have no toilet. It's one of many gigantic failures that have prompted Nobel prize-winning academic Amartya Sen to write a devastating critique of India's economic boom The roses are blooming at the window in the immaculately kept gardens of Trinity College, Cambridge and Amartya Sen is comfortably ensconced in a cream armchair facing shelves of his neatly catalogued writings. There are plenty of reasons for satisfaction...

-The Business Standard The new price caps for 191 essential drugs are likely to introduce serious distortions in the market for these medicines The National Pharmaceutical Pricing Authority, or NPPA, has announced new price caps for 191 essential drugs that are 10 to 50 per cent lower than the current prices. Drug makers have 45 days to recall the earlier batches and send out new ones with the lower price tags. This...